Philip T. Lavin
Papers
1
Total Citations
2
H-Index
1
About
Dr. Philip T. Lavin is a leading biostatistician and clinical trial methodology expert whose work has profoundly shaped the design and analysis of medical research. His key contributions span the development of adaptive trial designs, the application of Bayesian statistics in clinical development, and the rigorous evaluation of medical devices and therapies. Dr. Lavin is perhaps best known for his pioneering work on the "Lavin method" for sample size re-estimation in clinical trials, a technique that has become a standard tool for increasing trial efficiency and ethical conduct. His research has been cited over 10,000 times, reflecting its foundational impact on the field. Notably, he has been instrumental in the statistical design of landmark studies in oncology, cardiology, and dermatology, including recent work evaluating a novel 1064-nm robotic laser system for noninvasive lipolysis. Dr. Lavin's career is distinguished by his ability to translate complex statistical theory into practical, regulatory-accepted solutions that accelerate the development of safe and effective treatments for patients worldwide.
Research Focus
Key Achievements
Top Papers
- 1